Jamieson Wellness (JWEL) investor relations material

Strategic positioning and company overview

• Holds a leadership position in the Canadian vitamin, mineral, and supplement market, with 100 years of expertise and a strong focus on quality and innovation.

• Operates globally with multi-channel distribution, including food, drug, mass, ecommerce, and club channels.

• Brands address consumer health needs across all life stages, with Jamieson as the #1 VMS brand in Canada and youtheory as a leading U.S. brand.

• Maintains industry-leading quality assurance, with certifications from Health Canada, GMP, and TGA.

Financial performance and growth

• Achieved 2025 revenue of $822.1M CAD, with 2026 guidance of $895M–$935M CAD, reflecting 9.0%–13.7% growth.

• Adjusted EBITDA for 2025 was $159.7M, with 2026 guidance of $174M–$181M and a stable margin of ~19.4%.

• Adjusted diluted EPS projected to rise from $1.85 in 2025 to $2.08–$2.21 in 2026.

• Cash flow from operations before working capital expected to reach $120M–$130M in 2026.

• Annual dividend per share has grown at a 12.5% CAGR from 2021–2025, reaching $0.96 in 2026 guidance.

Market expansion and growth drivers

• U.S. market targeted for 14–19% growth in 2026, leveraging youtheory brand and channel expansion.

• China market expected to grow 25–35% in 2026, focusing on cross-border ecommerce, retail expansion, and brand building.

• Canadian market aims for 4–6% growth, maintaining leadership and expanding distribution.

• International segment targets 10–15% growth, with focus on emerging markets and regulatory readiness.

• Growth propelled by global health megatrends: aging population, rising health focus, and informed consumers.